{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:26:20Z","timestamp":1783077980612,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.abrep.2026.100674","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:34:58Z","timestamp":1770482098000},"page":"100674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment preferences of patients receiving opioid agonist therapy in spain: a discrete choice experiment"],"prefix":"10.1016","volume":"23","author":[{"given":"M.L.","family":"Dorado Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Alonso Ganuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.","family":"Henche Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marcos Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Orengo Caus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.F.","family":"Palma \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Rodr\u00edguez Cejas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-1090","authenticated-orcid":false,"given":"A.","family":"S\u00e1nchez M\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vega Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sucunza Guibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"G\u00f3mez-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Y\u00e9benes Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Crespo Portero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.abrep.2026.100674_b0005","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making\u2013pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.abrep.2026.100674_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108857","article-title":"Preferences for research design and treatment of comorbid depression among patients with an opioid use disorder: A cross-sectional discrete choice experiment","volume":"226","author":"Bastien","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.abrep.2026.100674_b0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication Treatment of Opioid Use Disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.abrep.2026.100674_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109578","article-title":"Public preferences for safe consumption sites for opioid use: A discrete choice experiment","volume":"238","author":"Berrigan","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.abrep.2026.100674_b0025","first-page":"109","article-title":"Motivational Interviewing: An Evidence-based Approach for use in Medical Practice","volume":"118","author":"Bischof","year":"2021","journal-title":"Deutsches Arzteblatt International"},{"issue":"2011","key":"10.1016\/j.abrep.2026.100674_b0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health-a checklist: A report of the ISPOR good research practices for conjoint analysis task force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.abrep.2026.100674_b0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.aprim.2017.06.006","article-title":"Abandono precoz y retenci\u00f3n en servicios ambulatorios de drogodependencias: An\u00e1lisis transversal comparativo de factores que aumentan o disminuyen la adherencia","volume":"50","author":"Calvo","year":"2018","journal-title":"Atenci\u00f3n Primaria"},{"issue":"4","key":"10.1016\/j.abrep.2026.100674_b0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hec.729","article-title":"Design techniques for stated preference methods in health economics","volume":"12","author":"Carlsson","year":"2003","journal-title":"Health economics"},{"key":"10.1016\/j.abrep.2026.100674_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.abrep.2026.100674_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104002","article-title":"'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue","volume":"115","author":"Clay","year":"2023","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.abrep.2026.100674_b0055","doi-asserted-by":"crossref","unstructured":"Colom, J., Szerman, N., Sabater, E., Ferre, F., Pascual, F., Gilabert-Perramon, A., Casado, M. \u00c1., Bobes, J., & M C D A-O U, D. (2021). Study to determine relevant health outcome measures in opioid use disorder: Multicriteria decision analysis. Estudio para la determinaci\u00f3n de medidas de resultados en salud relevantes en el trastorno por consumo de opi\u00e1ceos. An\u00e1lisis de decisi\u00f3n multicriterio. Adicciones, 33(2), 109\u2013120. DOI: 10.20882\/adicciones.1263.","DOI":"10.20882\/adicciones.1263"},{"issue":"2","key":"10.1016\/j.abrep.2026.100674_b0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: No Easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.abrep.2026.100674_b0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","article-title":"Sample size requirements for discrete-choice experiments in healthcare: A practical guide","volume":"8","author":"de Bekker-Grob","year":"2015","journal-title":"The Patient"},{"issue":"18","key":"10.1016\/j.abrep.2026.100674_b0070","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: A European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opinion On Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.abrep.2026.100674_b0075","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1037\/adb0000318","article-title":"Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness","volume":"31","author":"DiClemente","year":"2017","journal-title":"Psychology of addictive behaviors : Journal of the Society of Psychologists in Addictive Behaviors"},{"key":"10.1016\/j.abrep.2026.100674_b0080","doi-asserted-by":"crossref","unstructured":"Edwards, A., & Elwyn, G. (Eds.). (2009). Shared decision-making in health care: Achieving evidence-based patient choice (2.\u00aa ed.). Oxford University Press.","DOI":"10.1093\/oso\/9780199546275.003.0001"},{"key":"10.1016\/j.abrep.2026.100674_b0085","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2024: Trends and Developments. [internet]. Available at: https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2024_en. Access: June 2024."},{"issue":"2019","key":"10.1016\/j.abrep.2026.100674_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40271-019-00360-3","article-title":"Aguide to measuring and interpreting attribute importance","volume":"12","author":"Gonzalez","year":"2019","journal-title":"Patient - Patient-Center Outcomes Res"},{"issue":"1","key":"10.1016\/j.abrep.2026.100674_b0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1176\/appi.prcp.20180004","article-title":"Shared decision-making tool for treatment of perinatal opioid use disorder","volume":"1","author":"Guille","year":"2019","journal-title":"Psychiatric research and clinical practice"},{"issue":"5","key":"10.1016\/j.abrep.2026.100674_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13275","article-title":"The switching process from buprenorphine sublingual tablets to the monthly buprenorphine subcutaneous depot injection in opioid dependent patients","volume":"28","author":"Guillery","year":"2023","journal-title":"Addiction Biology"},{"key":"10.1016\/j.abrep.2026.100674_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: A report of the ISPOR conjoint analysis good research practices task force","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"3","key":"10.1016\/j.abrep.2026.100674_b0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0020764009354835","article-title":"Treatment goals in addiction healthcare: The perspectives of patients and clinicians","volume":"57","author":"Joosten","year":"2011","journal-title":"The International Journal Of Social Psychiatry"},{"issue":"1","key":"10.1016\/j.abrep.2026.100674_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12875-019-1047-z","article-title":"Attitudes of primary care physicians toward prescribing buprenorphine: A narrative review","volume":"20","author":"Louie","year":"2019","journal-title":"BMC Family Practice"},{"issue":"2","key":"10.1016\/j.abrep.2026.100674_b9005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","article-title":"Multiple criteria decision analysis for health care decision making\u2014emerging good practices: report 2 of the ISPOR MCDA Emerging Good Practices Task Force","volume":"19","author":"Marsh","year":"2016","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.abrep.2026.100674_b0130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1363461516660884","article-title":"Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America","volume":"53","author":"Mendoza","year":"2016","journal-title":"Transcultural Psychiatry"},{"issue":"12","key":"10.1016\/j.abrep.2026.100674_b0135","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/add.16620","article-title":"Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best-worst scaling task","volume":"119","author":"Metcalfe","year":"2024","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.abrep.2026.100674_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209138","article-title":"Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis","volume":"154","author":"Muthulingam","year":"2023","journal-title":"Journal of substance use and addiction treatment"},{"issue":"1","key":"10.1016\/j.abrep.2026.100674_b0145","first-page":"73","article-title":"Healthcare professionals\u2019 perception of prolonged-release buprenorphine in opioid use disorder","volume":"37","author":"Ora\u00e1","year":"2025","journal-title":"FOLIPRO Study. Adicciones"},{"issue":"4","key":"10.1016\/j.abrep.2026.100674_b0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.20882\/adicciones.1684","article-title":"Patients\u2019 satisfaction and experience in treatment with opioid substitution therapy in Spain","volume":"35","author":"Pascual Pastor","year":"2023","journal-title":"The PREDEPO study. Adicciones"},{"issue":"2","key":"10.1016\/j.abrep.2026.100674_b0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000520091","article-title":"Perception of a new prolonged-release buprenorphine formulation in patients with opioid use disorder: The PREDEPO study","volume":"28","author":"Pascual","year":"2022","journal-title":"European Addiction Research"},{"issue":"2013","key":"10.1016\/j.abrep.2026.100674_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: Report of the ISPOR conjoint analysis experimental design good research practices task force","volume":"16","author":"Reed","year":"2013","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"5","key":"10.1016\/j.abrep.2026.100674_b0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/17425247.2024.2369756","article-title":"Compared implementation of the long-acting buprenorphine treatment buvidal in four European countries","volume":"21","author":"Rolland","year":"2024","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.abrep.2026.100674_b0170","doi-asserted-by":"crossref","DOI":"10.2196\/43776","article-title":"Correlation between Opioid Drug Prescription and Opioid-Related Mortality in Spain as a Surveillance Tool: Ecological Study","volume":"9","author":"Salazar","year":"2023","journal-title":"JMIR Public Health and Surveillance"},{"key":"10.1016\/j.abrep.2026.100674_b0175","doi-asserted-by":"crossref","unstructured":"Serrano-P\u00e9rez P., Rivero-Santana A., Daigre-Blanco C., Palma-\u00c1lvarez R. F., Nistal-Franco I., Ramos-Quiroga J.A., Grau-L\u00f3pez L. (2024). Correlates of Control Preferences, Participation in Decision-making and Activation in Patients with Substance Use Disorder. Actas Esp Psiquiatr., 52(3), 192-203. https.\/\/doi.org\/ 10.62641\/aep.v52i3.1598.","DOI":"10.62641\/aep.v52i3.1598"},{"issue":"5","key":"10.1016\/j.abrep.2026.100674_b0180","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"The International Journal Of Neuropsychopharmacology"},{"key":"10.1016\/j.abrep.2026.100674_b0185","unstructured":"Spanish Observatory on Drugs and Addictions (OEDA) Statistics 2023. Alcohol, tobacco and illegal drugs in Spain, Madrid. Ministry of Health. Government Delegation for the National Plan on Drugs, 2023. 258p."},{"issue":"2","key":"10.1016\/j.abrep.2026.100674_b0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000456612","article-title":"Randomised comparison of a novel buprenorphine oral lyophilisate versus existing buprenorphine sublingual tablets in opioid-dependent patients: A first-in-patient phase ii randomised open label safety study","volume":"23","author":"Strang","year":"2017","journal-title":"European Addiction Research"},{"issue":"1","key":"10.1016\/j.abrep.2026.100674_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nature reviews. Disease Primers"},{"key":"10.1016\/j.abrep.2026.100674_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","article-title":"Multiple criteria decision analysis for healthcare decision making-an introduction: Report 1 of the ISPOR MCDA emerging good practices task force","volume":"19","author":"Thokala","year":"2016","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"1","key":"10.1016\/j.abrep.2026.100674_b0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: Development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"4","key":"10.1016\/j.abrep.2026.100674_b0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in addressing the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"The New England Journal of Medicine"}],"container-title":["Addictive Behaviors Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853226000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853226000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:03:33Z","timestamp":1783076613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352853226000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S2352853226000106"],"URL":"https:\/\/doi.org\/10.1016\/j.abrep.2026.100674","relation":{},"ISSN":["2352-8532"],"issn-type":[{"value":"2352-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment preferences of patients receiving opioid agonist therapy in spain: a discrete choice experiment","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abrep.2026.100674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100674"}}